V3 here soon-try beta now
Gene Search (GeneCards Home) | GeneCards Guide | User Feedback | Terms of Use | Notice about third-party sites
 

TP53 Gene

protein-coding   GIFtS: 82

GC17M007512
tumor protein p53
Symbol approved by the HUGO Gene Nomenclature Committee (HGNC) database
Services    
(According to 1HGNC, 2Entrez Gene,
3UniProtKB/Swiss-Prot, 4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc , and/or 7Ensembl, 8miRBase)
About This Section

Aliases
FLJ92943 2
LFS1 1, 2, 5
P53 3, 5
TRP53 2
p53 1, 2
Descriptions
Antigen NY-CO-13 3
Phosphoprotein p53 2, 3
Tumor suppressor p53 3
p53 antigen 2
p53 transformation suppressor 2
p53 tumor suppressor 2
transformation-related protein 53 2
tumor protein p53 2
External Ids
HGNC: 119981
Entrez Gene: 71572
UniProtKB: P046373
Ensembl: ENSG000001415107
Search outside databases for aliases for TP53 gene

Previous GC identifers: GC17P008026 GC17M008311 GC17M007514 GC17M007772

(According to Entrez Gene, Wikipedia's Gene Wiki,
UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL)
About This Section

EntrezGene summary for TP53:
This gene encodes tumor protein p53, which responds to diverse cellular stresses to regulate target
genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism.
p53 protein is expressed at low level in normal cells and at a high level in a variety of
transformed cell lines, where it's believed to contribute to transformation and malignancy.
p53 is a DNA-binding protein containing transcription activation, DNA-binding, and oligomerization
domains. It is postulated to bind to a p53-binding site and activate expression of downstream
genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. Mutants of p53
that frequently occur in a number of different human cancers fail to bind the consensus DNA
binding site, and hence cause the loss of tumor suppressor activity. Alterations of this gene
occur not only as somatic mutations in human malignancies, but also as germline mutations in some
cancer-prone families with Li-Fraumeni syndrome. Multiple p53 variants due to alternative
promoters and multiple alternative splicing have been found. These variants encode distinct
isoforms, which can regulate p53 transcriptional activity. [provided by RefSeq]

UniProtKB/Swiss-Prot: P53_HUMAN, P04637
Function: Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis
depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a
trans-activator that acts to negatively regulate cell division by controlling a set of genes
required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases.
Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression,
or by repression of Bcl-2 expression. Implicated in Notch signaling cross-over

Gene Wiki entry for TP53 (P53)

(According to GeneLoc and/or HGNC, and/or
Entrez Gene (NCBI build 36),
and/or miRBase,
Genomic Views according to UCSC and Ensembl, Transcription factor binding sites according to SABiosciences)
About This Section

Genomic View:
UCSC Golden Path with GeneCards custom track

 Transcription factor binding sites upstream to the TP53 gene  

Entrez Gene cytogenetic band: 17p13.1   Ensembl cytogenetic band:  17p13.1   HGNC cytogenetic band: 17p13.1

TP53 Gene in genomic location: bands according to Ensembl, locations according to (and/or Entrez Gene and/or Ensembl if different)

GeneLoc gene densities for chromosome 17         GeneLoc Exon Structure

GeneLoc location for GC17M007512:     (about GC identifiers)

Start:
7,512,445 bp from pter
End:
7,531,642 bp from pter
Size:
19,198 bases
Orientation:
minus strand
RefSeq DNA sequence:
NC_000017.9  NT_010718.15  
(According to 1UniProtKB, and/or Ensembl, Phosphorylation sites according to 2Phosphosite, RefSeq according to NCBI, PDB rendering according to OCA and/or Proteopedia, Recombinant Proteins from Invitrogen, Millipore, Sigma-Aldrich, R&D Systems, Enzo Life Sciences, Abnova, OriGene and/or, Abcam,
Biochemical Assays by Invitrogen, Millipore, R&D Systems, Cell Signaling Technology, and/or Enzo Life Sciences, Ontologies according to Gene Ontology Consortium 01 Apr 2009 and Entrez Gene, Antibodies by Invitrogen, Millipore, Sigma-Aldrich, R&D Systems, Cell Signaling Technology, Abcam, Abnova, and/or Novus Biologicals)
About This Section

UniProtKB/Swiss-Prot: P53_HUMAN, P04637 (See protein sequence)
Recommended Name: Cellular tumor antigen p53  
Size: 393 amino acids; 43712 Da
Cofactor: Binds 1 zinc ion per subunit
Subunit: Interacts with AXIN1. Probably part of a complex consisting of TP53, HIPK2 and AXIN1 (By
similarity). Binds DNA as a homotetramer. Interacts with histone acetyltransferases EP300 and
methyltransferases HRMT1L2 and CARM1, and recruits them to promoters. In vitro, the interaction of
TP53 with cancer-associated/HPV (E6) viral proteins leads to ubiquitination and degradation of
TP53 giving a possible model for cell growth regulation. This complex formation requires an
additional factor, E6-AP, which stably associates with TP53 in the presence of E6. Interacts (via
C-terminus) with TAF1; when TAF1 is part of the TFIID complex. Interacts with ING4; this
interaction may be indirect. Found in a complex with CABLES1 and TP73. Interacts with HIPK1,
HIPK2, and P53DINP1. Interacts with WWOX. May interact with HCV core protein. Interacts with USP7
and SYVN1. Interacts with HSP90AB1. Interacts with CHD8; leading to recruit histone H1 and prevent
transactivation activity (By similarity). Interacts with ARMC10, BANP, CDKN2AIP and E4F1.
Interacts with YWHAZ; the interaction enhances P53 transcriptional activity. Phosphorylation of
YWHAZ on 'Ser-58' inhibits this interaction. Interacts (via DNA-binding domain) with MAML1 (via
N-terminus)
Subcellular location: Cytoplasm. Nucleus. Endoplasmic reticulum. Note=Interaction with BANP
promotes nuclear localization
PDB structures from and Proteopedia :
1A1U (3D)    1AIE (3D)    1C26 (3D)    1DT7 (3D)    1GZH (3D)    1H26 (3D)    1HS5 (3D)    1JSP (3D)    
1KZY (3D)    1MA3 (3D)    1OLG (3D)    1OLH (3D)    1PES (3D)    1PET (3D)    1SAE (3D)    1SAF (3D)    
1SAH (3D)    1SAJ (3D)    1SAK (3D)    1SAL (3D)    1TSR (3D)    1TUP (3D)    1UOL (3D)    1XQH (3D)    
1YC5 (3D)    1YCQ (3D)    1YCR (3D)    1YCS (3D)    2AC0 (3D)    2ADY (3D)    2AHI (3D)    2ATA (3D)    
2B3G (3D)    2BIM (3D)    2BIN (3D)    2BIO (3D)    2BIP (3D)    2BIQ (3D)    2F1X (3D)    2FEJ (3D)    
2FOJ (3D)    2FOO (3D)    2GS0 (3D)    2H1L (3D)    2H2D (3D)    2H2F (3D)    2H4F (3D)    2H4H (3D)    
2H4J (3D)    2H59 (3D)    2J0Z (3D)    2J10 (3D)    2J11 (3D)    2J1W (3D)    2J1X (3D)    2J1Y (3D)    
2J1Z (3D)    2J20 (3D)    2J21 (3D)    2K8F (3D)    2OCJ (3D)    2PCX (3D)    2QVQ (3D)    2QXA (3D)    
2QXB (3D)    2QXC (3D)    2VUK (3D)    2Z5S (3D)    2Z5T (3D)    3D05 (3D)    3D06 (3D)    3D07 (3D)    
3D08 (3D)    3D09 (3D)    3D0A (3D)    3DAB (3D)    3DAC (3D)    3SAK (3D)    
Secondary accessions: Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q86UG1
Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61
Alternative splicing: 2 isoforms:  P04637-1   P04637-2   

Post-translational modifications:

  • Acetylated. Acetylation of Lys-382 by CREBBP enhances transcriptional activity. Deacetylation of
    Lys-382 by SIRT1 impairs its ability to induce proapoptotic program and modulate cell senescence1
  • Phosphorylation on Ser residues mediates transcriptional activation. Phosphorylated by HIPK1 (By
    similarity). Phosphorylation at Ser-9 by HIPK4 increases repression activity on BIRC5 promoter.
    Phosphorylated on Thr-18 by VRK1, which may prevent the interaction with MDM2. Phosphorylated on
    Thr-55 by TAF1, which promotes MDM2-mediated degradation. Phosphorylated on Ser-46 by HIPK2 upon
    UV irradiation. Phosphorylation on Ser-46 is required for acetylation by CREBBP. Phosphorylated on
    Ser-392 following UV but not gamma irradiation. Phosphorylated upon DNA damage, probably by ATM or
    ATR. Phosphorylated on Ser-15 upon ultraviolet irradiation; which is enhanced by interaction with
    BANP1
  • Dephosphorylated by PP2A. SV40 small T antigen inhibits the dephosphorylation by the AC form of
    PP2A1
  • May be O-glycosylated in the C-terminal basic region. Studied in EB-1 cell line1
  • Ubiquitinated by SYVN1, which leads to proteasomal degradation1
  • Monomethylated at Lys-372 by SETD7, leading to stabilize it and increase transcriptional
    activation. Monomethylated at Lys-370 by SMYD2, leading to decrease DNA-binding activity and
    subsequent transcriptional regulation activity. Lys-372 monomethylation prevents the interaction
    with SMYD2 and subsequenct monomethylation at Lys-3701
  • Sumoylated by SUMO11
  • Demethylation of di-methylated Lys-370 by KDM1/LSD1 prevents interaction with TP53BP1 and represses
    TP53-mediated transcriptional activation1
  • View phosphorylation sites using PhosphoSite2


  • REFSEQ proteins (7 alternative transcripts): 
    NP_000537.3  NP_001119584.1  NP_001119585.1  NP_001119586.1  NP_001119587.1  NP_001119588.1  NP_001119589.1  


    ENSEMBL proteins: 
    ENSP00000379735 ENSP00000352610 ENSP00000269305 


    Human Recombinant Proteins 
    Browse Drug Discovery Central at Invitrogen for human recombinant proteins
    Millipore Purified and/or Recombinant TP53 Protein
    Sigma-Aldrich CompoZr ZFN for TP53  
    Browse R&D Systems for human recombinant proteins
    Enzo Life Sciences proteins for TP53
    Recombinant Proteins from Abcam (p53 gamma, p53, p53 beta, Mutant p53)
    Human Recombinant Proteins from Abnova (TP53)
                  OriGene Purified Recombinant Human Protein: TP53 

    5/11 Gene Ontology (GO) cellular component terms (links to tree view) (see all 11 ):

    GO IDQualified GO termEvidencePubMed IDs
    GO:0005626 insoluble fraction IDA12915590
    GO:0005634 nucleus IDA7720704 16507995
    GO:0005654 nucleoplasm IDA11080164 12915590
    GO:0005657 replication fork IEA--
    GO:0005730 nucleolus IDA12080348
    About this table

    Antibodies for TP53: 
    Invitrogen Antibodies for TP53
    Millipore Mono- and Polyclonal Antibodies for the study of TP53
    Sigma-Aldrich Antibody Arrays and Antibodies for TP53
    R&D Systems Antibodies for TP53 (p53)
    Cell Signaling Technology (CST) Antibodies for TP53  (p53)
    Antibodies from Abcam (p53 gamma, p53, p53 beta, Mutant p53), each with their AbpromiseSM
    Monoclonal and Polyclonal Antibodies from Abnova (TP53)
    Novus Biologicals Antibodies for TP53

    Assays for TP53: 
    Invitrogen Assays for TP53
    Millipore Kits and Assays for the Analysis of TP53
    R&D Systems ELISAs for TP53 (p53)         (see all)
    Cell Signaling Technology (CST) Sandwich ELISA Kits for TP53 (p53)
    Browse biochemical assays available from Enzo Life Sciences

    (According to InterPro, ProtoNet, UniProtKB, and/or BLOCKS, Sets of similar genes according to GeneDecks)
    About This Section

    5/6 InterPro domains/families (see all 6 ):
     IPR011615 p53_DNA_bd
     IPR012346 p53_RUNT_DNA_bd
     IPR002117 p53_tumour_Ag
     IPR013872 p53_transactivation_domain
     IPR015551 Trp53


       GeneDecks  TP53 for the domains selected above  
    About GeneDecksing

    Graphical View of Domain Structure for InterPro Entry P04637

    ProtoNet protein and cluster: P04637

    1 Blocks protein family: IPB010991 p53

    UniProtKB/Swiss-Prot: P53_HUMAN, P04637
    Domain: The nuclear export signal acts as a transcriptional repression domain
    Similarity: Belongs to the p53 family

    (According to MGI Jun 06 2009, UniProtKB, IUBMB,and/or Genatlas,
    shRNA from OriGene, Sigma-Aldrich, RNAi from Sigma-Aldrich,
    RNAi Products, Clones, and Q-PCR Products from Invitrogen, Millipore, OriGene, and/or Abnova, siRNAs from Applied Biosystems, SYBR primers from OriGene, Cell-based Assays from Millipore, Ontologies according to Gene Ontology Consortium 01 Apr 2009 via Entrez Gene.)
    About This Section

    Inhib.
    RNA:
    Invitrogen RNAi Products for gene knock-down (TP53)
    Millipore RNAi Products for the Analysis of TP53 Gene knock-down
    Abnova Chimera RNAi Products for Gene knock-down (TP53)
                   OriGene 29mer shRNA kit in GFP-retroviral vectors (see all 7): NM_001126112

                  Applied Biosystems Silencer® siRNAs for TP53

                  Sigma-Aldrich siRNA for TP53  
                         Sigma-Aldrich shRNA Panels and shRNA for TP53  
                         Explore Sigma-Aldrich super-pooled esiRNAs  

    Clones:Invitrogen Clones for TP53
    Browse Clones for the Expression of Recombinant Proteins Available from Millipore
                   OriGene GFP tagged cDNA clones in CMV expression vector (see all 7): NM_000546
                                     Myc/DDK tagged cDNA clones in CMV expression vector (see all 7): NM_000546
                                     untagged cDNA clones in CMV expression vector (see all 7): NM_000546 

    Primers: Browse Quantitative PCR Central at Invitrogen for Q-PCR LUX™ Primers
                  OriGene genome-wide validated SYBR primer pairs: NM_000546

    UniProtKB/Swiss-Prot: P53_HUMAN, P04637
    Function: Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis
    depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a
    trans-activator that acts to negatively regulate cell division by controlling a set of genes
    required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases.
    Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression,
    or by repression of Bcl-2 expression. Implicated in Notch signaling cross-over

    Genatlas biochemistry entry for TP53:
    tumor suppressor protein p53 required for G1 growth arrest by WAF1 (CDKN1A),following DNA damage or
    induction of apoptosis,also regulating a G2 checkpoint through cyclin B1,transcriptional activator
    through acetylation of transactivation site by CREBBP binding MDM2 resulting in transcriptional
    silencing and ubiquitin/proteasome dependent degradation of p53,activated by conjugation to UBL1
    (SUMO1),putative up-regulated c-MYC target gene,putative teratologic suppressor gene and modulator
    of TFIIH (GTF2H),associated in nucleotide excision repair,activated by ATM in association with
    14.3.3 proteins (YWHA*),tumor suppressor gene (see TSG17A),mutated in cancers such as pancreas and
    endometrial carcinomas,in Barrett's adenocarcinoma (and esophageal squamous cell carcinoma),in
    hepatocellular carcinoma with poor prognosis

    15/29 MGI mutant phenotypes (inferred from 44 alleles(MGI details for Trp53) (see all 29 ):

    adipose tissuebehavior/neurologicalcellularcraniofacial
    digestive/alimentaryembryogenesisendocrine/exocrine glandgrowth/sizehearing/vestibular/ear
    hematopoietic systemhomeostasis/metabolismimmune systemlethality-postnatallethality-prenatal/perinatal

    5/12 Gene Ontology (GO) molecular function terms (links to tree view) (see all 12 ):

    GO IDQualified GO termEvidencePubMed IDs
    GO:0000739 DNA strand annealing activity IDA8183576
    GO:0003682 chromatin binding IDA17599062
    GO:0003700 transcription factor activity IDA7587074
    GO:0004518 nuclease activity TAS11002423
    GO:0005507 copper ion binding IDA7824276
    About this table

    (Pathways according to Invitrogen (maps by GeneGo), Millipore, Cell Signaling Technology, Sigma-Aldrich, KEGG and/or UniProtKB,
    Sets of similar genes according to GeneDecks, Proteins Network according to SABiosciences, Interactions according to 1UniProtKB, 2MINT, and/or 3STRING, with links to IntAct and Ensembl, Ontologies according to Gene Ontology Consortium 01 Apr 2009 via Entrez Gene.)
    About This Section

    5/19 Invitrogen iPath™ Online BioAtlas - Pathways for TP53 (see all 19 ) (Maps provided by GeneGo):
     Putative integrins pathway. Part 2
     PTEN pathway
     Putative SUMO-1 pathway
     P53 signaling pathway
     Cell Cycle Regulation by Brca1

       GeneDecks  TP53 for the pathways selected above  
    About GeneDecksing

    5/16 Millipore Pathways for TP53 (see all 16 )
     DNA damage ATM/ATR regulation of G1/S checkpoint
     Proteolysis Putative SUMO-1 pathway
     Immune response MIF in innate immunity response
     DNA damage DNA-damage-induced responses
     DNA damage Role of SUMO in p53 regulation

       GeneDecks  TP53 for the pathways selected above  
    About GeneDecksing

    5/31 Sigma-Aldrich "Your Favorite Gene" Pathways for  TP53  (Your Favorite Gene powered by Ingenuity) (see all 31
     Prostate Cancer Signaling
     Role of CHK Proteins in Cell Cycle Checkpoint Control
     Molecular Mechanisms of Cancer
     Chronic Myeloid Leukemia Signaling
     Basal Cell Carcinoma Signaling

       GeneDecks  TP53 for the pathways selected above  
    About GeneDecksing

    5 Cell Signaling Technology (CST) Pathways for TP53: 
     Cell Cycle Control: G2/M DNA Damage Checkpoint
     Mitochondrial Control of Apoptosis
     Akt/PKB Signaling
     SAPK/JNK Signaling Cascades
     Cell Cycle Control: G1/S Checkpoint

       GeneDecks  TP53 for the pathways selected above  
    About GeneDecksing

    5/20 Kegg Pathways  (Kegg details for TP53) (see all 20 ):
     hsa04010 MAPK signaling pathway
     hsa04110 Cell cycle
     hsa04115 p53 signaling pathway
     hsa04210 Apoptosis
     hsa04310 Wnt signaling pathway

       GeneDecks  TP53 for the pathways selected above  
    About GeneDecksing
     Gene Network CentralTM Interacting Genes and Proteins Network for  TP53 


    5/824 Interacting proteins for TP53 (ENSP000002693053 P046371, 2) via UniProtKB, MINT, and/or STRING (see all 824 )
    InteractantInteraction Details
    GeneCardExternal ID(s)
    UBCP629881, 2STRING (score=.999) EBI-366083, EBI-413034 MINT-4051326 MINT-4304004 MINT-4054804 MINT-4304143 MINT-6801380 MINT-6615153 MINT-6541035 MINT-6799774 MINT-7013815 MINT-4052207 MINT-5114741
    - - (xeno)Q9PST71EBI-366083, EBI-617698 MINT-69740 MINT-6628483 MINT-6733190 MINT-69730 MINT-73318 MINT-6628495 MINT-6628706 MINT-6733198 MINT-73205 MINT-73319 MINT-6627917 MINT-6628699 MINT-5162111 MINT-6628692 EBI-366083, EBI-1782562
    RPS27AP11P629881, 2EBI-366083, EBI-413034 MINT-4051326 MINT-4304004 MINT-4054804 MINT-4304143 MINT-6801380 MINT-6615153 MINT-6541035 MINT-6799774 MINT-7013815 MINT-4052207 MINT-5114741
    RPS27AP12P629881, 2EBI-366083, EBI-413034 MINT-4051326 MINT-4304004 MINT-4054804 MINT-4304143 MINT-6801380 MINT-6615153 MINT-6541035 MINT-6799774 MINT-7013815 MINT-4052207 MINT-5114741
    RPS27AP16P629881, 2EBI-366083, EBI-413034 MINT-4051326 MINT-4304004 MINT-4054804 MINT-4304143 MINT-6801380 MINT-6615153 MINT-6541035 MINT-6799774 MINT-7013815 MINT-4052207 MINT-5114741
    UBA52P629881, 2EBI-366083, EBI-413034 MINT-4051326 MINT-4304004 MINT-4054804 MINT-4304143 MINT-6801380 MINT-6615153 MINT-6541035 MINT-6799774 MINT-7013815 MINT-4052207 MINT-5114741
    UBBP629881, 2EBI-366083, EBI-413034 MINT-4051326 MINT-4304004 MINT-4054804 MINT-4304143 MINT-6801380 MINT-6615153 MINT-6541035 MINT-6799774 MINT-7013815 MINT-4052207 MINT-5114741
    About this table

    5/48 Gene Ontology (GO) biological process terms (links to tree view) (see all 48 ):

    GO IDQualified GO termEvidencePubMed IDs
    GO:0000060 protein import into nucleus, translocation IEA--
    GO:0000122 negative regulation of transcription from RNA polymerase II promoter IEA--
    GO:0001701 in utero embryonic development IEA--
    GO:0001836 release of cytochrome c from mitochondria IEA--
    GO:0002309 T cell proliferation during immune response IEA--
    About this table
    (Chemical Compounds according to UniProtKB, Enzo Life Sciences, Sigma-Aldrich, Tocris Bioscience, and/or Novoseek and Drugs according to Enzo Life Sciences and/or PharmGKB)
    About This Section

    Browse drugs & compounds from Enzo Life Sciences
    Browse Small Molecules at Sigma-Aldrich

    Compounds for TP53 available from Tocris Bioscience
    CompoundAction CAS number
    CP 31398 dihydrochloridep53-stabilizing agent[259199-65-0]
    RETRA hydrochlorideAntitumor agent; suppresses mutant p53-bearing cancer cells[1036069-26-7]
    Pifithrin-alpha hydrobromidep53 inhibitor. Also aryl hydrocarbon receptor agonist[63208-82-2]
    MIRA-1Restores mutant p53 activity; proapoptotic[72835-26-8]
    RITAp53-MDM2 interaction inhibitor; antitumor[213261-59-7]
    About this table


    10/18 Novoseek chemical compound relationships for TP53 gene (see all 18 )
    Compound   Score   Articles   PubMed IDs for Articles with Shared Sentences (# sentences)
    hpvs 70.81 69 11002226 (2), 8726818 (2), 9714244 (1), 10029413 (1) (see all 48)
    noxa 70.34 71 17216584 (4), 17653088 (3), 15598651 (3), 15878356 (2) (see all 41)
    progesterone 68.44 658 12416559 (6), 14595509 (5), 9635673 (5), 9744308 (5) (see all 99)
    aflatoxin b1 63.74 200 16280384 (6), 8921985 (5), 1310637 (5), 10446974 (5) (see all 88)
    advexin 57.44 9 19086841 (2), 16856803 (2), 12749760 (2), 17483435 (1)
    crcs 56.64 37 10533474 (4), 16084947 (3), 11037343 (2), 19147861 (2) (see all 18)
    bpde 55.33 104 7586197 (6), 17630511 (6), 10786695 (5), 17942461 (4) (see all 32)
    dutp 51.24 18 11920781 (1), 14761612 (1), 11867201 (1), 14739302 (1) (see all 15)
    proline 51.05 271 14612423 (7), 11053443 (6), 8986812 (4), 16054204 (4) (see all 99)
    o6-methylguanine 48.25 18 14724564 (2), 19107440 (1), 19047896 (1), 10945617 (1) (see all 13)
    About this table

    2 PharmGKB drug compound relationships for TP53 gene
    Drug compound PharmGKB Relations PubMed IDs for articles supporting these relationships
    mercaptopurineCO  PD  PK  FA  GN  12704389 10406363
    methotrexatePD  FA  GN  12704389
    About this table


    (GenBank/EMBL/DDBJ Accessions according to
    Unigene (Build 219 Homo sapiens; Jun 2 2009) or GenBank,
    RefSeq according to Entrez Gene,
    DOTS (version 10), and/or AceView,
    non coding RNAs according to RNAdb,
    ESTs according to GeneTide,
    exon structure from GeneLoc, alternative splicing isoforms according to ASD and/or ECgene,
    RNAi Products from Invitrogen, Millipore, and/or Abnova,
    siRNAs from Applied Biosystems, Sigma-Aldrich,
    shRNA from Sigma-Aldrich, OriGene,
    Tagged/untagged cDNA clones from OriGene,
    Expression Assays from Applied Biosystems)
    About This Section

    Inhib.
    RNA:
    Invitrogen RNAi Products for gene knock-down (TP53)
    Millipore RNAi Products for the Analysis of TP53 Gene knock-down
    Abnova Chimera RNAi Products for Gene knock-down (TP53)
                   OriGene 29mer shRNA kit in GFP-retroviral vectors (see all 7): NM_001126112

                  Sigma-Aldrich siRNA for TP53  
                         Sigma-Aldrich shRNA Panels and shRNA for TP53  
                         Explore Sigma-Aldrich super-pooled esiRNAs  

    Applied Biosystems Silencer® siRNAs: 

    NM_000546  NM_001126112  NM_001126113  NM_001126114  NM_001126115  NM_001126116  NM_001126117  

    REFSEQ mRNAs for TP53 gene (7 alternative transcripts): 

    NM_000546.4   NM_001126112.1   NM_001126113.1   NM_001126114.1   NM_001126115.1   NM_001126116.1   NM_001126117.1   

    Applied Biosystems TaqMan ® Gene Expression Assays: 

    NM_000546  NM_001126112  NM_001126113  NM_001126114  NM_001126115  NM_001126116  NM_001126117  

                   OriGene GFP tagged cDNA clones in CMV expression vector (see all 7): NM_000546
                                     Myc/DDK tagged cDNA clones in CMV expression vector (see all 7): NM_000546
                                     untagged cDNA clones in CMV expression vector (see all 7): NM_000546 

    Additional cDNA sequence: 

    AB082923.1 AF052180.1 AF307851.1 AK223026.1 AK225838.1 AK297462.1 AK297927.1 AK303277.1 
    AK312568.1 AM076970.1 AM076971.1 AM076972.1 AY429684.1 AY627884.1 BC003596.1 BT019622.1 
    CR608294.1 CR624912.1 DQ186648.1 DQ186649.1 DQ186650.1 DQ186651.1 DQ186652.1 DQ191317.1 
    DQ263704.1 DQ286964.1 DQ401704.1 DQ485152.1 DQ648883.1 DQ648884.1 DQ648885.1 DQ648886.1 
    DQ648887.1 EF101867.1 EF101868.1 EF101869.1 FJ207420.1 M14694.1 M14695.1 S66666.1 
    X01405.1 X02469.1 X60010.1 X60011.1 X60012.1 X60013.1 X60014.1 X60015.1 
    X60016.1 X60017.1 X60018.1 X60019.1 X60020.1 

    18 DOTS entries:

    DT.92469229  DT.100788714  DT.120961435  DT.100788713  DT.75152217  DT.40283865  DT.95274968  DT.100712946 
    DT.120961349  DT.100788719  DT.40120491  DT.120961395  DT.100788715  DT.92010563  DT.120961350  DT.120961391 
    DT.120961408  DT.99987012 

    24/112 AceView cDNA sequences (see all 112 ):

    AW865736 X02469 AA379547 AA291539 AY627884 S66666 X60018 BE886147 
    AI539544 CK904490 CR608294 BU174921 AA358870 X60016 BQ057682 BQ066009 
    BX952582 CA432254 AA662570 BU673953 X60012 CR624912 BQ923115 AB082923 

    1 RNAdb entry of non coding RNAs:

    LIT1750   

    highest scoring ESTs for TP53:

    X02469 AA171861 AA296373 AB082923 AF307851 AU076984 AU120569 AU121050 AU129655 AU131952 

    Unigene Cluster for TP53:

    Tumor protein p53
    Hs.654481  [show with all ESTs]
    Unigene Representative Sequence: NM_001126114


    GeneLoc Exon Structure

    5/9 Alternative Splicing Database (ASD) splice patterns (SP) for TP53 (see all 9 )

    ExUns: 1a · 1b ^ 2 ^ 3 ^ 4 ^ 5a · 5b ^ 6 ^ 7 ^ 8 ^ 9a · 9b ^ 10a · 10b ^ 11 ^ 12a · 12b · 12c
    SP1:                                -                             -           -     -                           
    SP2:                                                              -                                             
    SP3:                                                              -           -                                 
    SP4:                                                              -           -     -                           
    SP5:                                                                          -     -                           

    About this scheme

    ECgene alternative splicing isoforms for TP53

    3 Ensembl transcripts including schematic representations:
    ENST00000396473  ENST00000359597  ENST00000269305  
    (Experimental results according to 1GeneNote and GNF BioGPS,
    probe sets-to-genes annotations according to 2GeneAnnot , 3GeneTide , Sets of similar genes according to GeneDecks, Electronic Northern calculations according to data from UniGene (Build 219 Homo sapiens), SAGE tags according to CGAP, plus additional links to SOURCE, and/or GNF BioGPS, and/or EXPOLDB, and/or UniProtKB,
    Expression Assays from Applied Biosystems )
    About This Section

    TP53 expression in normal and diseased human tissues

     Applied Biosystems TaqMan ® Gene Expression Assays for TP53

    1 / 2 / 3

    7 probe-sets matching TP53 gene


    Affymetrix
    probe-set
    Array  GeneAnnot data GeneNote data GeneTide data
    # genes Sensitivity Specificity Correlation Length Gb_Accession Consensus Uniqueness Score Rank

    1974_s_at2, 3 U95-A 1 1.00 1.00 0.82 0.88 X02469 1.00 1.00 1.00 1
    1939_at2, 3 U95-A 1 1.00 1.00 0.74 1.29 M22898 0.20 1.00 0.72 1

    31618_at2, 3 U95-A 1 1.00 1.00 0.54 0.84 S66666 0.60 1.00 0.82 1

    211300_s_at2, 3 U133-A 1 1.00 1.00 -- -- K03199 0.80 1.00 0.91 1

    201746_at2, 3 U133-A 1 1.00 1.00 -- -- NM_000546 0.60 1.00 0.82 1

    211300_s_at2 U133Plus2 1 1.00 1.00 -- -- -- -- -- -- --

    201746_at2 U133Plus2 1 1.00 1.00 -- -- -- -- -- -- --
    GeneDecks  TP53 for binary patterns associated with the probe-sets selected above  
    About GeneDecksing
    About this table    
    Data from (Publications) and GNF BioGPS
        About these images
    About these images

    CGAP SAGE TAG: TTTTGTAGAG

    SOURCE GeneReport for Unigene cluster: Hs.654481

    Expression variation in blood from EXPOLDB for TP53

    (Orthologs according to 1,2HomoloGene (2older version, for species not in 1newer version), 3euGenes, 4SGD and/or 5MGI Jun 06 2009, with possible further links to Flybase and/or WormBase, Gene Trees according to Ensembl)
    About This Section


    Orthologs for TP53 gene from 5/8 species (see all 8 )
    Organism Gene Locus Description Human
    Similarity
    NCBI accessions
    dog
    (Canis familiaris)
    TP531   -- tumor protein p53 84.3(n)
    83.42(a)
    403869  NM_001003210.1  NP_001003210.1 
    chimpanzee
    (Pan troglodytes)
    TP531   -- tumor protein p53 99.75(n)
    100(a)
    455214  XM_001172091.1  XP_001172091.1 
    cow
    (Bos taurus)
    TP531   -- tumor protein p53 83.9(n)
    82.08(a)
    281542  NM_174201.2  NP_776626.1 
    rat
    (Rattus norvegicus)
    Tp531   -- tumor protein p53 81.44(n)
    78.35(a)
    24842  NM_030989.1  NP_112251.1 
    mouse
    (Mus musculus)
    Trp531, 5 11 (39.00 cM)5
    transformation related protein 531, 5 80.45(n)1
    78.29(a)1
    220591  NM_011640.11  NP_035770.11 
     AB0178155  AB0178165  (see all 52)
    About this table        Species with no ortholog for TP53

    ENSEMBL Gene Tree for TP53
    (Paralogs according to 1HomoloGene
    and 2Ensembl, Pseudogenes according to 3Pseudogene.org)
    About This Section

    Paralogs for TP53 gene
    TP732  TP632  

    (According to the 1NCBI SNP Database, 2Ensembl, 3PupaSUITE, and UniProtKB, Linkage Disequilibrium by HapMap, Genotyping Reagents from Applied Biosystems)
    About This Section


    10/340 NCBI SNPs in TP53 are shown (see all 340 )
    (Click for Applied Biosystems TaqMan ® Genotyping Assay)  (see all 120)
    ABGenomic DataTranscription DataAllele Frequencies
    SNP IDValidChr 17 posSequenceRecsAA
    Chg
    TypeMoreRecsAllele
    freq
    PopTotal
    sample
    More
    ------------
    rs18003711,2
    C,F,H,O7520273(-) TGTCCC/TCGGAC 4 P/S mis1 ese313Minor allele frequency- T:0.01MN NA NS EU EA WA 1326
    rs10425221,2
    A,C,F,H7520197(-) TCCCCG/CCGTGG 4 R/P mis122Minor allele frequency- C:0.44MN CSAM EA NS EU WA 2320
    rs29094301,2
    A,C,F,H7519370(-) CTTACA/GCATGT 4 -- int1 ut5114Minor allele frequency- G:0.12NS MN CSAM EA EU WA 1418
    rs98958291,2
    C,F,H7519404(+) GCTAGA/GGAGAG 4 -- ut51 int110Minor allele frequency- G:0.09EU EA WA NS MN CSAM 974
    rs16149841,2
    A,C,F7512177(-) TAGGAC/TTGGGC 1 -- ng516Minor allele frequency- T:0.40NS MN CSAM EA 582
    --
    rs49681871,2
    C,F,H7513167(+) TAGACC/TCCATG 7 -- ut3116Minor allele frequency- T:0.05NS EU EA WA MN CSAM 1660
    rs178837821,2
    C,F7512431(-) TGCAGG/CCTACT 1 -- ng517Minor allele frequency- C:0.01NS 842
    --
    rs178863581,2
    C,F7513083(-) AGCTGGT/-TAGGT 7 -- ut316Minor allele frequency- -:0.02NS MN CSAM EA 580
    --
    rs115406541,2
    C,H7520083(-) TTTCCC/G/TTCTGG 8 R/P R/L mis1 ese39MN CSAM EA EU WA 814
    rs178813661,2
    C,F7513324(-) TCACCG/ATACTA 7 -- ut31 ese36Minor allele frequency- A:0.01NS MN CSAM EA 588
    About this table

    HapMap Linkage Disequilibrium images for TP53 (up to first 250kb)

    (in which this Gene is Involved, According to OMIM, UniProtKB, Novoseek, PharmGKB, Genatlas, GeneTests, Blood group antigen gene mutations by BGMUT, HGMD, GAD, HuGE Navigator, BCGD, and/or TGDB.)
    About This Section

    OMIM: 191170   disorders: 114500  151623  114550  259500  260500  161550  260350  202300  114480  151623  

    UniProtKB/Swiss-Prot: P53_HUMAN, P04637

  • TP53 is found in increased amounts in a wide variety of transformed cells. TP53 is
    frequently mutated or inactivated in about 60% of cancers
  • Defects in TP53 are involved in esophageal squamous cell carcinoma (ESCC) [MIM:133239].
    ESCC is a tumor of the esophagus
  • Defects in TP53 are a cause of Li-Fraumeni syndrome (LFS) [MIM:151623]. LFS is an
    autosomal dominant familial cancer syndrome that in its classic form is defined by the existence
    of a proband affected by a sarcoma before 45 years with a first degree relative affected by any
    tumor before 45 years and another first degree relative with any tumor before 45 years or a
    sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819 and
    PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives
    develop a diverse set of malignancies at unusually early ages. Four types of cancers account for
    80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone
    sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include
    choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5,
    leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers
  • Defects in TP53 may be associated with nasopharyngeal carcinoma [MIM:161550]; also known
    as nasopharyngeal cancer
  • Defects in TP53 are found in Barrett metaplasia; also known as Barrett esophagus. It is a
    condition in which the normally stratified squamous epithelium of the lower esophagus is replaced
    by a metaplastic columnar epithelium. The condition develops as a complication in approximately
    10% of patients with chronic gastroesophageal reflux disease and predisposes to the development of
    esophageal adenocarcinoma
  • Defects in TP53 are involved in head and neck squamous cell carcinomas (HNSCC)
    [MIM:275355]
  • Defects in TP53 are involved in oral squamous cell carcinoma (OSCC). Cigarette smoke is a
    prime mutagenic agent in cancer of the aerodigestive tract
  • Defects in TP53 are a cause of lung cancer [MIM:211980]
  • Defects in TP53 are a cause of choroid plexus papilloma [MIM:260500]. Choroid plexus
    papilloma is a slow-growing benign tumor of the choroid plexus that often invades the
    leptomeninges. In children it is usually in a lateral ventricle but in adults it is more often in
    the fourth ventricle. Hydrocephalus is common, either from obstruction or from tumor secretion of
    cerebrospinal fluid. If it undergoes malignant transformation it is called a choroid plexus
    carcinoma. Primary choroid plexus tumors are rare and usually occur in early childhood
  • Defects in TP53 are a cause of one form of hereditary adrenocortical carcinoma (ADCC)
    [MIM:202300]. ADCC is a rare childhood tumor, representing about 0.4% of childhood tumors, with a
    high incidence of associated tumors. ADCC occurs with increased frequency in patients with the
    Beckwith-Wiedemann syndrome [MIM:130650] and is a component tumor in Li-Fraumeni syndrome
    [MIM:151623]
  • 10/97 Novoseek disease relationships for TP53 gene (see all 97 )

    Disease   Score   Articles   PubMed IDs for Articles with Shared Sentences (# sentences)
    tumors 93.74 22625 8777377 (10), 7901994 (9), 8007011 (9), 8324748 (8) (see all 99)
    li-fraumeni syndrome 90.46 320 1373881 (5), 17483435 (3), 10980596 (3), 10484981 (3) (see all 99)
    cancer 89.81 6346 17598983 (10), 18223686 (8), 15055300 (7), 12561442 (7) (see all 99)
    carcinoma 87.49 3225 9110348 (10), 8062281 (9), 16033093 (8), 7927312 (8) (see all 99)
    carcinoma squamous cell 86.80 1827 9127380 (8), 8826924 (7), 10445528 (6), 11255264 (6) (see all 99)
    retinoblastoma 85.08 679 10792093 (8), 9337350 (6), 11306502 (5), 8224613 (5) (see all 99)
    microsatellite instability 84.49 335 9731891 (6), 9716224 (5), 11290569 (5), 12612901 (5) (see all 99)
    allelic loss 83.88 399 16293976 (5), 7909153 (5), 8467510 (4), 11520271 (4) (see all 99)
    adenocarcinoma 82.64 1486 12823203 (7), 17982662 (7), 9379505 (6), 10674608 (6) (see all 99)
    breast cancer 81.53 2563 7917542 (8), 8679460 (8), 12170762 (7), 15566648 (6) (see all 99)
    About this table

    5 PharmGKB disease relationships for TP53 gene
    Disease PharmGKB Relations PubMed IDs for articles supporting these relationships
    Leukemia, LymphocyticCO  PK  GN  10406363
    Leukemia, Lymphocytic, Acute, L1PD  FA  GN  12704389
    Neoplasms, Radiation-InducedCO  PK  GN  10406363
    Neoplasms, Second PrimaryCO  PK  GN  10406363
    Ovarian NeoplasmsCO  GN  15221786
    About this table

    GeneTests: TP53
    Li-Fraumeni Syndrome

    Human Gene Mutation Database: TP53
    Genetic Association Database: TP53
    Human Genome Epidemiology Navigator: TP53 (724 documents)
    Tumor Gene Database: TP53
    Breast Cancer Gene Database: TP53

    (Possibly Related Articles in Doctor's Guide)
    About This Section

    (in PubMed. Associations of this gene to articles via 1Novoseek, 2HGNC, 3Entrez Gene, 4UniProtKB/Swiss-Prot, 5UniProtKB/TrEMBL, 6GAD, and/or 7PharmGKB)
    About This Section

    10/11043 PubMed articles for TP53 gene (see all 11043 ):
    (in PubMed, OMIM, and NCBI Bookshelf)
    About This Section

     ANDOR
    Aliases
    Disorders
    Free Text  

      Query String
    PubMed
    OMIM
    NCBI Bookshelf
      (Note: In FireFox, select the above section and copy using Ctrl-C)
    (According to Entrez Gene, HGNC, AceView, euGenes, Ensembl, miRBase, ECgene, and/or H-InvDB)
    About This Section

    Entrez Gene: 7157 HGNC: 11998 AceView: TP53 Ensembl:ENSG00000141510 euGenes: HUgn7157
    ECgene: TP53 H-InvDB: TP53
    (According to HUGE)
    About This Section

      --
    (According to ATLAS, HORDE, IMGT, MTDB, LEIDEN, UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL,
    Wikipedia and/or GeneReviews via UniProtKB/Swiss-Prot)
    About This Section

    NameDescription
    ATLAS Chromosomes in Cancer entry for TP53 Genetics and Cytogenetics in Oncology and Haematology
    IARC TP53 mutation databasehttp://www-p53.iarc.fr/
    p53 web site at the Institut Curiehttp://p53.free.fr/
    GeneReviewshttp://www.genetests.org/query?gene=TP53
    NIEHS-SNPshttp://egp.gs.washington.edu/data/tp53/
    SHMPDhttp://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=TP53
    Wikipedia http://en.wikipedia.org/wiki/P53
    (Available from WIS Yeda, Salk, Tufts)
    About This Section

    Licensable Technologies for TP53 gene:
     Weizmann Institute:Treatment of Systemic Lupus Erythematosus by Down-Regulating the Autoimmune Response to Autoantigens    (see all 2)
     Salk Institute: Assays for p53 Function in Cells

    (Reagents available from Applied Biosystems, Antibodies and assays by Cell Signaling Technology, Abcam, Novus Biologicals,
    Sigma-Aldrich, R&D Systems, Millipore, Abnova, and/or Invitrogen, Clones available from OriGene,and/or Invitrogen, Drugs and/or compounds by Sigma-Aldrich,
    Enzo Life Sciences, and/or Tocris Bioscience)
    About This Section



    Products for TP53:
     TaqMan ® Gene Expression Assays
     TaqMan ® Genotyping Assays
      Free SNP selection tool



      Invitrogen iPath Pathways  Invitrogen BLOCK-iT™ RNAi
      Invitrogen Antibodies  Invitrogen Assays
      Invitrogen Clones  Invitrogen Q-PCR Products
      Invitrogen Human Recombinant Kinases  Invitrogen Custom Antibody and Peptide Service
      Invitrogen Proteins / Assays / Screening Services  Search Invitrogen catalog for TP53-related products

     Millipore Custom Antibody & Bulk Services
     Millipore Preclinical / Clinical Development Services
     Millipore Immunoassay Services
     Millipore Target Screening & Profiling Services


     Predesigned and custom siRNAs for TP53 Antibodies for TP53
     Explore super-pooled esiRNAs Proteins for TP53
     Lentivirus-delivered shRNAs for TP53 Browse small molecules at Sigma-Aldrich
     "Your Favorite Gene" Pathwaysfeedback


      
     Antibodies   Primer Pairs  
     Cell Culture Products   ELISAs  
     Flow Cytometry Kits   Protease Activity Assays & Reagents  
     Cell Selection/Detection Kits & Reagents   ELISA/Assay Development Kits & Reagents  
     Multiplex/Array Assay Kits & Reagents   ELISpot Kits & Development Modules  
     Recombinant & Natural Proteins  

     Recombinant Proteins (TP53)
     Antibodies (TP53)
     Chimera RNAi (TP53)
     Custom Service for Mouse Mab
     Custom Service for Rabbit Pab from Full-length Protein
      
     Antibodies & Assays for TP53  (p53)

     Recombinant Proteins
    (p53 gamma, p53, p53 beta, Mutant p53)
     Antibodies (p53 gamma, p53, p53 beta, Mutant p53)
     Tagged/untagged cDNA clones
     Validated SYBR primer pairs
     Purified proteins from HEK293T cells
     Western blot validated antibodies
     shRNA in GFP-retroviral vector
     Tocris compounds for TP53




     Proteins for TP53
     Search www.enzolifesicences.com for proteins, assays, substrates, inhibitors & antibodies
     Antibodies for TP53

    GeneCards Homepage    -    Last full update: 2 Jul 2009        Incremental update: 13 Oct 2009

    Random Gene From GIFtS : about GIFtS

    Gene Index:   3   5   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z

    Developed at the Crown Human Genome Center & Weizmann Institute of Science



    The GeneCards Human Gene Database: Copyright © 1996-2009, Weizmann Institute of Science. All Rights Reserved.
    TP53 Gene at Home site.
    Version 2.41.1
    server5.xennexinc.com